Akso Health Group has started a new research and development program focused on next-generation brain-computer interface (BCI) technology, aiming to create innovations in neural sensing, AI neural decoding, and interface design. This initiative is intended to build a long-term growth engine for the company by addressing unmet needs in neuroscience, therapeutics, and human-machine interaction. The company has not yet begun human trials or regulatory submissions and cautions that product development and commercialization are uncertain. Akso Health currently operates in medical device sales and online medical consultations in China and the US.
The global polypropylene market is projected to grow from 102.7 million tons in 2026 to 139.2 million tons by 2032, with a CAGR of 5.14%. Growth is fueled by rising demand for lightweight automotive parts, mono-material flexible packaging, and high-m...
At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
James Talarico, a Democrat recently elected to the U.S. Senate from Texas, voted twice in favor of establishing a strategic Bitcoin reserve for the state. This proposal aims to create a state-level Bitcoin reserve, reflecting growing bipartisan suppo...
Riot Platforms sold 20,264 Bitcoin in the first nine months of 2026, generating about $1.5 billion mainly used for data-center construction. Despite a 1% revenue increase to $181 million in Q3, Bitcoin mining revenue dropped due to lower Bitcoin pric...
